Literature DB >> 17040288

Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.

Yoriko Yamashita1, Tatsuya Tsurumi, Naoyoshi Mori, Tohru Kiyono.   

Abstract

The genes required for immortalization of human B cells infected by Epstein-Barr virus are multiple, and the precise mechanism of this process remains to be elucidated. In the present study HPV16 E6 and E7 were retrovirally transduced into human primary B cells stimulated by CD40-CD40L interaction, thereby establishing an Epstein-Barr virus negative immortalized human B cell line, which continued to proliferate for more than 2 years (100 population doublings). The established cell line had a high telomerase activity from the beginning of the culture period, and no shortening of the telomere length was observed. A chromosomal analysis revealed that a large portion of the HPV16E6E7 transduced cells had retained a normal karyotype. Similar to human epithelial cells, human B lymphocytes seem to require two steps for immortalization, namely, the inactivation of the p16/Rb pathway and the activation of telomerase, the latter that can be induced by the CD40-CD40L interaction. Furthermore, using this system, it is possible to analyze the role of individual genes in human B lymphocyte immortalization without the influence of a pre-existing Epstein-Barr virus genome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17040288     DOI: 10.1111/j.1440-1827.2006.02026.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis.

Authors:  Hirotaka Nagai; Yasumasa Okazaki; Shan Hwu Chew; Nobuaki Misawa; Yoriko Yamashita; Shinya Akatsuka; Toshikazu Ishihara; Kyoko Yamashita; Yutaka Yoshikawa; Hiroyuki Yasui; Li Jiang; Hiroki Ohara; Takashi Takahashi; Gaku Ichihara; Kostas Kostarelos; Yasumitsu Miyata; Hisanori Shinohara; Shinya Toyokuni
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  A novel method for efficient collection of normal mesothelial cells in vivo.

Authors:  Li Jiang; Yoriko Yamashita; Shinya Toyokuni
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

Review 3.  CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.

Authors:  E Kondo; L Gryschok; N Klein-Gonzalez; S Rademacher; M R Weihrauch; T Liebig; A Shimabukuro-Vornhagen; M Kochanek; A Draube; M S von Bergwelt-Baildon
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

4.  Expression of P-REX2a is associated with poor prognosis in endometrial malignancies.

Authors:  Sho Takeshita; Yoriko Yamashita; Kosuke Shiomi; Nako Suzuki; Jun Yoshida; Aya Naiki-Ito; Shugo Suzuki; Shinya Akatsuka; Shinya Toyokuni; Takashi Takahashi; Shoko Mase; Atsushi Arakawa; Mayumi Sugiura-Ogasawara; Satoru Takahashi
Journal:  Oncotarget       Date:  2018-05-15

5.  Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.

Authors:  Yoriko Yamashita; Shinya Akatsuka; Kanako Shinjo; Yasushi Yatabe; Hiroharu Kobayashi; Hiroshi Seko; Hiroaki Kajiyama; Fumitaka Kikkawa; Takashi Takahashi; Shinya Toyokuni
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

6.  Role of hemoglobin and transferrin in multi-wall carbon nanotube-induced mesothelial injury and carcinogenesis.

Authors:  Yue Wang; Yasumasa Okazaki; Lei Shi; Hiro Kohda; Minoru Tanaka; Kentaro Taki; Tomoki Nishioka; Tasuku Hirayama; Hideko Nagasawa; Yoriko Yamashita; Shinya Toyokuni
Journal:  Cancer Sci       Date:  2016-02-18       Impact factor: 6.716

7.  Ovarian endometriosis-associated stromal cells reveal persistently high affinity for iron.

Authors:  Masahiko Mori; Fumiya Ito; Lei Shi; Yue Wang; Chiharu Ishida; Yuka Hattori; Masato Niwa; Tasuku Hirayama; Hideko Nagasawa; Akira Iwase; Fumitaka Kikkawa; Shinya Toyokuni
Journal:  Redox Biol       Date:  2015-10-21       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.